Trek Therapeutics, PBC

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal i

Biopharma has been talking for years about the necessity for a new business model, one that reconciles the aim of expanding patient access to the latest medicine at a price point conducive to supporti

The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between Feb. 17 and Feb. 23, 2017, divided

Amid tough market conditions, Medivir AB CEO Niklas Prager is "convinced" that a sale of its Nordic Brands portfolio – operating as BioPhausia AB – to Karo Pharma "is the best way to maximize